CorMedix Inc.

CRMDNASDAQ • USD
4.82 USD
↗ 0.16 (3.43%)AT CLOSE (03:59 PM EST)
4.87
↗ 0.05 (0.95%)
POST MARKET (AS OF 07:30 PM EST)
Post Market
AS OF 07:30 PM EST
4.87
↗ 0.05 (0.95%)
🔴Market: CLOSED

CorMedix Inc. (CRMD) trades at $4.81 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a weak Piotroski F-Score of 1/9, exceptional Return on Equity (40.6%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, CRMD appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$5.05
High?$5.23
Low?$4.75
Prev. Close?$4.66
Volume?3.2M
Avg. Volume?1.8M
VWAP?$4.93
Rel. Volume?1.83x
Bid / Ask
Bid?$4.85 × 500
Ask?$4.91 × 100
Spread?$0.06
Midpoint?$4.88
Valuation & Ratios
Market Cap?370.6M
Shares Out?79.5M
Float?70.5M
Float %?90.4%
P/E Ratio?1.98
P/B Ratio?0.80
EPS?$2.35
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Employees
191
Market Cap
370.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2010-05-13
Address
389 INTERPACE PKWY, SUITE 450
PARSIPPANY, NJ 07054
Phone: 908-517-9500
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
36
Momentum?
23
Short Sent.?
25
Piotroski F-Score?1/9Weak
Altman Z-Score?2.02Grey
Confidence?70%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?20.15%Squeeze Risk
Short Interest?14.2M
Days to Cover?8.4
Free Float70.5M
Avg Daily Volume1.7M
Settlement Date2026-10-30
Financial Health
Current Ratio?2.56Strong
Quick Ratio?2.36Strong
Cash Ratio?1.37Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
Peers
100
S&P
97
2.0CHEAP▾
P/B?
Peers
100
S&P
97
0.80CHEAP▾
P/S?
Peers
100
S&P
90
0.80CHEAP▾
P/FCF?
Peers
100
S&P
97
1.5CHEAP▾
EV/EBITDA?
Peers
100
S&P
97
0.5CHEAP▾
EV/Sales?
Peers
100
S&P
97
0.25CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
88
40.6%STRONG▾
ROA?
Peers
50
S&P
97
20.7%STRONG▾
Cash Flow & Enterprise
FCF?$250.4M
Enterprise Value?$114.0M
Fundamentals ratios updated end of day